share_log

荣昌生物拟获一系列实控人增持股份 涉资1000万至2000万元

Remegen plans to obtain a series of shareholding from actual controllers, involving 10 million to 20 million yuan.

新浪港股 ·  Jul 8 20:12

Remegen (09995) announced that its actual controllers Wang Weidong, Fang Jianmin, Lin Jian, Wang Liqiang, Wang Xudong, Deng Yong, Xiong Xiaobin, Yang Minhua, Wen Qingkai and Wei Jianliang continue to be bullish on the company's operations and confident in its future development prospects. They plan to increase their shareholding in the company through Yantai Rongchang Holding Group Co., Ltd., which they control, in a manner permitted by the Shanghai Stock Exchange trading system (including but not limited to centralized bidding, continuous bidding, and block trades) starting from July 9, 2024 for six months. The amount of the shareholding increase shall not be less than RMB 10 million and shall not exceed RMB 20 million.

The announcement stated that the purpose of this shareholding increase is to further demonstrate recognition of the company's long-term investment value, support the implementation of the company's development strategy, and promote its sustained, healthy and stable development based on continuous bullishness on the company's operations and confidence in its future development prospects.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment